Logo image of ALREA.PA

REALITES (ALREA.PA) Stock Fundamental Analysis

EPA:ALREA - Euronext Paris - Matif - FR0011858190 - Common Stock - Currency: EUR

1.225  -0.02 (-1.61%)

Fundamental Rating

2

Taking everything into account, ALREA scores 2 out of 10 in our fundamental rating. ALREA was compared to 10 industry peers in the Real Estate Management & Development industry. ALREA may be in some trouble as it scores bad on both profitability and health. ALREA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALREA has reported negative net income.
ALREA had a negative operating cash flow in the past year.
In the past 5 years ALREA has always been profitable.
In the past 5 years ALREA always reported negative operating cash flow.
ALREA.PA Yearly Net Income VS EBIT VS OCF VS FCFALREA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M -60M

1.2 Ratios

ALREA has a worse Return On Assets (-8.46%) than 75.76% of its industry peers.
With a Return On Equity value of -263.66%, ALREA is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -8.46%
ROE -263.66%
ROIC N/A
ROA(3y)0.85%
ROA(5y)1.16%
ROE(3y)6.67%
ROE(5y)8.11%
ROIC(3y)N/A
ROIC(5y)N/A
ALREA.PA Yearly ROA, ROE, ROICALREA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

ALREA's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of ALREA has declined.
With a Gross Margin value of 6.23%, ALREA is not doing good in the industry: 69.70% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ALREA has declined.
The Profit Margin and Operating Margin are not available for ALREA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.23%
OM growth 3Y-9.64%
OM growth 5Y-8.44%
PM growth 3Y-39.02%
PM growth 5Y-26.59%
GM growth 3Y-21.24%
GM growth 5Y-8.32%
ALREA.PA Yearly Profit, Operating, Gross MarginsALREA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

More info and screens

2

2. Health

2.1 Basic Checks

ALREA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALREA has been reduced compared to 1 year ago.
ALREA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALREA has been reduced compared to a year ago.
ALREA.PA Yearly Shares OutstandingALREA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
ALREA.PA Yearly Total Debt VS Total AssetsALREA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.13, we must say that ALREA is in the distress zone and has some risk of bankruptcy.
ALREA's Altman-Z score of 0.13 is on the low side compared to the rest of the industry. ALREA is outperformed by 72.73% of its industry peers.
A Debt/Equity ratio of 5.29 is on the high side and indicates that ALREA has dependencies on debt financing.
ALREA has a worse Debt to Equity ratio (5.29) than 84.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.29
Debt/FCF N/A
Altman-Z 0.13
ROIC/WACCN/A
WACC4.12%
ALREA.PA Yearly LT Debt VS Equity VS FCFALREA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M

2.3 Liquidity

ALREA has a Current Ratio of 1.12. This is a normal value and indicates that ALREA is financially healthy and should not expect problems in meeting its short term obligations.
ALREA has a Current ratio of 1.12. This is comparable to the rest of the industry: ALREA outperforms 43.94% of its industry peers.
ALREA has a Quick Ratio of 1.12. This is a bad value and indicates that ALREA is not financially healthy enough and could expect problems in meeting its short term obligations.
ALREA's Quick ratio of 0.60 is in line compared to the rest of the industry. ALREA outperforms 42.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.6
ALREA.PA Yearly Current Assets VS Current LiabilitesALREA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

ALREA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -749.71%.
The earnings per share for ALREA have been decreasing by -18.27% on average. This is quite bad
The Revenue for ALREA has decreased by -14.96% in the past year. This is quite bad
The Revenue has been growing by 24.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-749.71%
EPS 3Y-27.37%
EPS 5Y-18.27%
EPS Q2Q%-2429.92%
Revenue 1Y (TTM)-14.96%
Revenue growth 3Y25.21%
Revenue growth 5Y24.65%
Sales Q2Q%-35.09%

3.2 Future

ALREA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.57% yearly.
Based on estimates for the next years, ALREA will show a small growth in Revenue. The Revenue will grow by 4.30% on average per year.
EPS Next Y-92.63%
EPS Next 2Y-27.45%
EPS Next 3Y-5.57%
EPS Next 5YN/A
Revenue Next Year-19.74%
Revenue Next 2Y-0.24%
Revenue Next 3Y4.3%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALREA.PA Yearly Revenue VS EstimatesALREA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
ALREA.PA Yearly EPS VS EstimatesALREA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ALREA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ALREA is valuated cheaply with a Price/Forward Earnings ratio of 1.19.
98.48% of the companies in the same industry are more expensive than ALREA, based on the Price/Forward Earnings ratio.
ALREA is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 1.19
ALREA.PA Price Earnings VS Forward Price EarningsALREA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALREA.PA Per share dataALREA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

ALREA's earnings are expected to decrease with -5.57% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.45%
EPS Next 3Y-5.57%

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.89%, ALREA is a good candidate for dividend investing.
ALREA's Dividend Yield is rather good when compared to the industry average which is at 3.79. ALREA pays more dividend than 87.88% of the companies in the same industry.
ALREA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 8.89%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALREA.PA Yearly Dividends per shareALREA.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 0.5 1 1.5

5.3 Sustainability

DP0%
EPS Next 2Y-27.45%
EPS Next 3Y-5.57%
ALREA.PA Yearly Income VS Free CF VS DividendALREA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

More info and screens

REALITES

EPA:ALREA (6/18/2025, 7:00:00 PM)

1.225

-0.02 (-1.61%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-25 2024-07-25
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners57.55%
Ins Owner ChangeN/A
Market Cap5.87M
Analysts86.67
Price Target17.85 (1357.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 8.89%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.19
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B 0.18
P/tB 0.23
EV/EBITDA N/A
EPS(TTM)-17.82
EYN/A
EPS(NY)1.03
Fwd EY84.08%
FCF(TTM)-11.51
FCFYN/A
OCF(TTM)-12.8
OCFYN/A
SpS70.22
BVpS6.75
TBVpS5.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.46%
ROE -263.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.23%
FCFM N/A
ROA(3y)0.85%
ROA(5y)1.16%
ROE(3y)6.67%
ROE(5y)8.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.63%
ROCE(5y)5.41%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-9.64%
OM growth 5Y-8.44%
PM growth 3Y-39.02%
PM growth 5Y-26.59%
GM growth 3Y-21.24%
GM growth 5Y-8.32%
F-Score2
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 5.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.27%
Cap/Sales 1.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.6
Altman-Z 0.13
F-Score2
WACC4.12%
ROIC/WACCN/A
Cap/Depr(3y)86.13%
Cap/Depr(5y)113.76%
Cap/Sales(3y)3.59%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-749.71%
EPS 3Y-27.37%
EPS 5Y-18.27%
EPS Q2Q%-2429.92%
EPS Next Y-92.63%
EPS Next 2Y-27.45%
EPS Next 3Y-5.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.96%
Revenue growth 3Y25.21%
Revenue growth 5Y24.65%
Sales Q2Q%-35.09%
Revenue Next Year-19.74%
Revenue Next 2Y-0.24%
Revenue Next 3Y4.3%
Revenue Next 5YN/A
EBIT growth 1Y-308.42%
EBIT growth 3Y13.14%
EBIT growth 5Y14.13%
EBIT Next Year149.51%
EBIT Next 3Y68.3%
EBIT Next 5YN/A
FCF growth 1Y0.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.11%
OCF growth 3YN/A
OCF growth 5YN/A